Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • POCUS
    • Literature Lounge
    • History of HM
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Career
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Learning
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • From JHM
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • POCUS
    • Literature Lounge
    • History of HM
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Career
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Learning
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • From JHM
  • Industry Content
    • Patient Monitoring with Tech

Search

9998 results

  • Introducing The Bookshelf

    September 2, 2026

    The Hospitalist is debuting a new section on the website called The Bookshelf. If you’re an SHM member who’s published a book, we want to showcase your accomplishment. Send us a cover image...

  • Article

    Apixaban Carries Lower Bleeding Risk Than Rivaroxaban in Acute VTE

    • Naveed Choudry, MD, FACP, FHM

    September 2, 2026

    Clinical Question: In patients with acute venous thromboembolism (VTE), is apixaban associated with a lower risk of clinically relevant bleeding than rivaroxaban? Background: Apixaban and...

  • Article

    Lost in Transition: Teens Falling Through the Cracks After ED Mental Health Visits

    • Meghan Connelly, MD

    September 2, 2026

    Clinical Question: Among adolescents with depression or suicidal ideation discharged from the emergency department (ED), what factors are associated with timely primary care follow-up? Background:...

  • Article

    Adding Ticagrelor to Aspirin After CABG for Acute Coronary Syndrome Does Not Improve One- Year Cardiovascular Outcomes and Increases Bleeding Risk

    • Raphael Pristoop, MD, FACP

    September 2, 2026

    Clinical Question: In patients undergoing CABG for acute coronary syndrome, does one year of dual antiplatelet therapy with ticagrelor plus aspirin improve clinical outcomes compared with aspirin...

  • Article

    Targeted Inpatient Correction of Chronic Hyponatremia Does Not Improve Short-Term Clinical Outcomes

    • Amanda Magee, DO, FACP, SFHM

    September 2, 2026

    Clinical Question: Does targeted correction of chronic hyponatremia in hospitalized patients reduce 30-day mortality or rehospitalization compared with routine care? Background: Chronic hyponatremia...

  • Article

    Pleural Effusions Requiring Drainage Are Associated with Lower Survival in Veterans with Cancer, CHF, or Pneumonia

    • Christina Maguire, MD

    September 2, 2026

    Clinical Question: Does the presence of a clinically significant pleural effusion have an impact on survival in patients with an admitting diagnosis of cancer, congestive heart failure (CHF), or...

  • Article

    Discontinuation of ACEIs/ARBs During AKI in Hospitalized Patients Decreases All-Cause Mortality

    • Eliana Bonifacino MD, MS

    September 2, 2026

    Clinical Question: Does discontinuation of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) during an episode of acute kidney injury (AKI) improve clinical...

  • Article

    Anti-Xa Monitoring During Therapeutic LMWH Use Leads to Frequent Dose Changes Without Clear Evidence of Improved Clinical Outcomes

    • Shaunak Kulkarni, MD

    September 2, 2026

    Clinical Question: In patients receiving therapeutic low-molecular-weight heparin (LMWH), does anti-Xa monitoring with subsequent dose adjustment improve bleeding or thrombotic outcomes? Background:...

  • Article

    Daily Fish-Oil Supplementation Reduced Serious Cardiovascular Events in Patients with End-Stage Kidney Disease Who Receive Maintenance Hemodialysis

    • David Fink, MD

    September 2, 2026

    Clinical Question: Does daily supplementation with omega-3 polyunsaturated fatty acids reduce cardiovascular events in patients on maintenance hemodialysis? Background: Cardiovascular disease is the...

  • Article

    IV Iron Administration During Acute Infection Does Not Worsen Outcomes and Is Associated with Improved Survival and Hemoglobin Recovery

    • Soumya Narayan, MD

    September 2, 2026

    Clinical Question: In hospitalized adults with iron-deficiency anemia (IDA) and concurrent acute infection, does IV iron administration improve clinical outcomes or worsen the infection? Background:...

1 2 3 … 1,000Next
Advanced Filters
 - 
Clear All
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
  • Copyright © 2026 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • Cookie Preferences